Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
315
datasets available to search
ShareScore release 0.9.0
Dataset results
315 results for “MTOR”
Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L)
ClinicalTrials.gov study NCT06385496. IPD Sharing: YES. Countries: 1. Publications: 0.
Sapu003 in Advanced mTOR-sensitive Solid Tumors
ClinicalTrials.gov study NCT07369505. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostat
ClinicalTrials.gov study NCT01548807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
mTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.
ClinicalTrials.gov study NCT05198427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leucine, MTOR and Athero
ClinicalTrials.gov study NCT05470218. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer
ClinicalTrials.gov study NCT01217177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
ClinicalTrials.gov study NCT02646319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
ClinicalTrials.gov study NCT01028092. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00985374. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
ClinicalTrials.gov study NCT05997056. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly [SubStudy Rapa & cMRI to Evaluate Cardiac Function]
ClinicalTrials.gov study NCT04742777. IPD Sharing: YES. Countries: 1. Publications: 0.
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
ClinicalTrials.gov study NCT03580239. IPD Sharing: NO. Countries: 1. Publications: 0.
Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer
ClinicalTrials.gov study NCT02306135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
ClinicalTrials.gov study NCT04936971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
ClinicalTrials.gov study NCT01510119. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse
ClinicalTrials.gov study NCT00926107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.
ClinicalTrials.gov study NCT07203664. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAF
ClinicalTrials.gov study NCT04993872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MTOR Inhibitors in Older Adults
ClinicalTrials.gov study NCT06727305. IPD Sharing: NO. Countries: 1. Publications: 0.
mTOR as Mediator of Insulin Sensitivity Study
ClinicalTrials.gov study NCT05233722. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.